Acute Myeloid Leukemia (AML) affects both children and adults, but the disease presents distinctly different challenges depending on age. Understanding these differences is crucial for patients, families, and caregivers navigating this complex blood cancer diagnosis.
AML represents approximately 15-20% of childhood leukemias and is the most common acute leukemia in adults. While the fundamental disease mechanism remains similar across age groups, significant variations exist in symptoms, treatment response, and long-term outcomes. These age-related differences directly impact treatment approaches and prognosis.
